glp-1 employer healthcare costs A Cost That's Hard to (G)u(LP-1) Down GLP-1 Agonists: Managing Employee Health

Biomed Pharmacother 2021;140:111778.ArticlePubMed 58

This is particularly important with tirzepatide, which can reduce oral contraceptive exposure during initiation and dose escalation, potentially requiring backup contraception

Patients should have access to these therapies, said Dr Matthew Klebanoff, assistant professor of internal medicine at the Perelman School of Medicine who has studied prior authorization policies for GLP-1 drugs

Theyre the same molecules your biologic is designed to block

Critically, the retatrutide data also showed that weight loss had not plateaued by the end of the trial period

This can be discussed further in detail with your provider